Judy D. Olian
Judy D. Olian's purchase track record
Judy D. Olian has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/20/2026 | ARES | $60K | +2.4% | +17.4% | +11.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
United Therapeutics Settles Litigation, Market Reassesses Valuation. United Therapeutics has settled a litigation that impacts its pulmonary hypertension business. The settlement resets competition in that market and has led analysts to question whether the stock is undervalued. The move may prompt a reassessment of the company’s value by investors.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Mattel sees sale pressure, adds water parks and Batman collectible. Recent reports note that Mattel’s shares have faced selling pressure, prompting analysts to say the stock appears fairly valued. The company announced a new water‑park line aimed at offsetting slower Barbie sales, and unveiled a premium Batman figure at the New York Comic Con. A major shareholder has signaled the possibility of a sale, while large‑cap investors have been active in the stock.
Transaction History
| ARES | ▲ Buy | Grant | 1,728 | $0 | 7/30/2026 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 1,310 | $0 | 7/9/2026 | View on chart |
| MAT | ▲ Buy | Option Exercise | 8,594 | — | 5/15/2026 | View on chart |
| UTHR | ▼ Sell | Open Market | 200 | $106K | 3/23/2026 | View on chart |
| UTHR | ▼ Sell | Open Market | 200 | $107K | 3/16/2026 | View on chart |
| UTHR | ▼ Sell | Open Market | 200 | $102K | 3/6/2026 | View on chart |
| UTHR | ▼ Sell | Open Market | 200 | $102K | 2/27/2026 | View on chart |
| ARES | ▲ Buy | Open Market | 480 | $60K | 2/20/2026 | View on chart |
| UTHR | ▼ Sell | Open Market | 1,800 | $748K | 9/19/2025 | View on chart |
| ARES | ▲ Buy | Grant | 1,166 | $0 | 7/31/2025 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 1,190 | $0 | 7/25/2025 | View on chart |
| MAT | ▲ Buy | Option Exercise | 6,843 | — | 5/23/2025 | View on chart |
| ARES | ▼ Sell | Gift | 397 | $0 | 12/12/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 1,750 | $722K | 11/11/2024 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 2,300 | $258K | 9/17/2024 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 2,300 | $812K | 9/17/2024 | View on chart |
| ARES | ▲ Buy | Grant | 1,173 | $0 | 8/1/2024 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 1,800 | $0 | 7/13/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 1,700 | $502K | 6/17/2024 | View on chart |
| ARES | ▼ Sell | Open Market | 3,417 | $458K | 6/7/2024 | View on chart |
| MAT | ▲ Buy | Option Exercise | 7,539 | — | 5/24/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 170 | $44K | 5/3/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 1,228 | $315K | 5/3/2024 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 10,000 | $1.8M | 5/3/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 1,829 | $472K | 5/3/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 5,616 | $1.5M | 5/3/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 1,157 | $300K | 5/3/2024 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 5,000 | $877K | 3/12/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 2,500 | $620K | 3/12/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 1,750 | $436K | 3/12/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 750 | $185K | 3/12/2024 | View on chart |
| UTHR | ▼ Sell | Gift | 950 | — | 11/29/2023 | View on chart |
| MAT | ▲ Buy | Option Exercise | 12,601 | — | 7/31/2023 | View on chart |
| ARES | ▲ Buy | Grant | 1,732 | $0 | 7/27/2023 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 1,750 | $0 | 7/7/2023 | View on chart |
| ARES | ▼ Sell | Open Market | 1,200 | $103K | 5/23/2023 | View on chart |
| UTHR | ▼ Sell | Open Market | 1,150 | $318K | 1/3/2023 | View on chart |
| UTHR | ▼ Sell | Open Market | 1,010 | $285K | 12/9/2022 | View on chart |
| UTHR | ▼ Sell | Open Market | 600 | $159K | 11/8/2022 | View on chart |
| UTHR | ▼ Sell | Gift | 1,125 | — | 11/7/2022 | View on chart |
| ARES | ▲ Buy | Grant | 2,787 | $0 | 7/28/2022 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 2,160 | $0 | 7/8/2022 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 10,000 | $1.8M | 6/27/2022 | View on chart |
| UTHR | ▼ Sell | Open Market | 700 | $169K | 6/27/2022 | View on chart |
| UTHR | ▼ Sell | Open Market | 9,300 | $2.2M | 6/27/2022 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 10,000 | $1.8M | 5/26/2022 | View on chart |
| UTHR | ▼ Sell | Open Market | 10,000 | $2.3M | 5/26/2022 | View on chart |
| MAT | ▲ Buy | Grant | 4,636 | $105K | 5/25/2022 | View on chart |
| MAT | ▲ Buy | Option Exercise | 12,567 | — | 5/16/2022 | View on chart |
| UTHR | ▼ Sell | Gift | 920 | — | 11/23/2021 | View on chart |
| MAT | ▲ Buy | Option Exercise | 6,518 | — | 9/13/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Ares Management Faces UBS Downgrade Amid Energy Stake
UBS maintained a Neutral rating on Ares Management but lowered its price target to $134. This move comes as the firm takes a minority stake in Statera’s 1.9GW flexible energy assets. The stock is currently trading near its 52-week low, reflecting broader market caution despite recent strategic investments.
Ares Management Faces UBS Downgrade Amid Energy Stake. UBS maintained a Neutral rating on Ares Management but lowered its price target to $134. This move comes as the firm takes a minority stake in Statera’s 1.9GW flexible energy assets. The stock is currently trading near its 52-week low, reflecting broader market caution despite recent strategic investments.